Group A bovine rotaviruses (BRV) have been identified worldwide as a major cause of diarrhea in the young of many species, including humans. Group A rotaviruses are classified into serotypes on the basis of the outer capsid proteins, VP7 (G types) and VP4 (P types). To date, there are 14 G types of group A rotaviruses, with G1, G6, G8, and G10 described for BRV isolates. In this study, G6-and G lo-specific monoclonal antibodies (MAbs) were used in an enzyme-linked immunosorbent assay (ELISA) for the G typing of BRV-positive stool samples from diarrheic beef and dairy calves from South Dakota, Ohio, Michigan, Nebraska, and Washington, USA, and Ontario, Canada. ELISA plates were coated using a broadly reactive VP7 MAb (Common 60) or with G6-or G10-specific MAbs. BRV-positive fecal samples were diluted and added to duplicate wells, followed by the addition of polyclonal guinea pig anti-group A rotavirus serum as the secondary antibody. Several reference G6 and G10 BRV strains as well as other G types previously reported in cattle (G1, G2, G3, G8) and BRV-negative samples were included as G type specificity and negative controls. From a total of 308 field samples analyzed, 79% (244/308) tested positive by the broadly reactive VP7 MAb; of these, 54% (131/244) were G6 positive, 14% (35/244) were G10 positive, 4% (9/244) were both G6 and G10 positive, and 28% (69/244) were G6 and G10 negative. The negative samples may represent additional or undefined serotypes. The 89 samples from South Dakota were further subdivided into samples from beef ( n = 43) or dairy (n = 46) herds. G6 was more prevalent in beef herd samples (67%) than in dairy herd samples (47.5%). In addition, dairy herds had higher percentages of G10-positive samples (17.5%) G6-G10 double positives (10%), and untypable samples (25%) than did beef herds, in which the prevalence of G10 positive samples was 5.5%, G6-G10 double positives was 5.5%, and untypable samples was 22%. Application of the serotype ELISA for the analysis of additional BRV samples will provide further epidemiologic data on the distribution of BRV serotypes in beef or dairy cattle, an important consideration for the development of improved BRV vaccines.
Group A rotaviruses have been identified worldwide as a major cause of diarrhea in the young of many species, including humans. 2, 6, 9, 20, 32, 36 Two rotavirus outer capsid proteins, VP4 and VP7, are independently involved in virus neutralization. 13 Group A rotaviruses are classified into G serotypes on the basis of the outer capsid glycoprotein VP7. 6, 12, 13 To date, 14 G types have been described for group A rotaviruses, with G1, G6, G8, and G10 described for group A bovine rotaviruses (BRV). [2] [3] [4] 6, 14, 19, 23, 31, 34, 38 VP4 is also a determinant of rotavirus serotype specificity (P types). However, limited serotypic characterization on the basis of VP4 speci-ficity has been reported for human and animal rotaviruses. 6, 17, 24, 25 Earlier methods for the serotyping of rotaviruses included the use of fluorescent focus neutralization and plaque reduction virus neutralization assays. 6, 14 Recently, several investigators have developed procedures for the G typing of human and animal group A rotaviruses, including the use of a monoclonal antibody (MAb)-based enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction assays, and nucleic acid probes. 2, 5, 8, 9, 23, 25, 29, 31, 33 The use of G-typespecific MAbs in an ELISA system offers a rapid, sensitive, and relatively inexpensive method for the screening and serotyping of rotaviruses in a large number of fecal samples.
Investigators in other countries have reported the use of the ELISA for the G typing of BRV isolates, 2, 3, 6, 31 but there have been no reports of serotyping BRV field isolates from the USA using either G6-or G10-specific MAbs. Such data are useful from an epidemiologic standpoint and provide important information nec-essary for the development and monitoring of effective tibodies to BRV, as determined by PRVN assays 16 and in-BRV vaccines. direct immunofluorescence tests. 35 The objectives of this study were to produce and characterize neutralizing MAbs for the development of a MAb-based ELISA for the G typing of field strains of BRV detected from calves with diarrhea from South Dakota, Ohio, Michigan, Nebraska, and Washington, USA, and Ontario, Canada. The broadly reacting VP7specific MAb (Common 60) and both G6-and G10specific MAbs were used in separate ELISAs. In addition, the frequencies of G6 and G10 types in samples from beef versus dairy calves were examined for the samples from South Dakota.
Materials and methods
Fecal samples. Three hundred eight rotavirus-positive fecal samples and 7 BRV-negative samples collected between 1988 and 1992 from diarrheic calves from South Dakota (n = 162) Ohio a,b (n = 70) Michigan c (n = 33) Nebraska d (n = 26) Washington e (n = 3) and Ontario f (n = 14) were analyzed. The samples from South Dakota were from beef (n = 43) and dairy (n = 46) herds or were samples of unspecified beef or dairy origin (n = 73). Most of the other samples, including all from Ohio, Michigan, Washington, and Ontario, were from dairy herds. Group A rotavirus detection in the feces of calves from South Dakota, Ohio, Michigan, Nebraska, and Washington was performed by 1 or more of the following techniques: ELISA, 18 immune electron microscopy, 26 immunofluorescence, 35 or polyacrylamide gel electrophoresis of rotavirus double-stranded RNA. 11,27 Group A rotavirus detection in calf feces from Ontario was performed using a rotavirus group A antiserum in a latex agglutination test. Seven samples determined negative for rotavirus by the above techniques and collected during the same period from Ohio (n = 5) Nebraska (n = 1), and Ontario (n = 1) were also analyzed as negative controls.
Production of MAbs. MAbs BR16D3 and BRC11F6 were produced using techniques similar to those described previously. 16, 37 Two separate groups of 6-8-wk-old BALB/c female mice were immunized intraperitoneally with semipurified BRV G6 Cody strain or G10 Cr strain in complete Freund's adjuvant. Two weeks later, virus was administered intraperitoneally in incomplete Freund's adjuvant. 16 After an additional 2 wk, mice were boosted intravenously with virus in PBS (pH 7.4). Three days after the final booster, spleen cells were fused with SP2/0 myeloma cells by the use of 50% polyethylene glycol (molecular weight = 3,350). g When hybridomas occupied at least 30% of the well area, culture supernatants were screened by antibody production against Cody or Cr BRV strains, respectively, by a cell culture immunofluorescence (CCIF) test 16,35,37 and a fluorescent focus neutralization (FFN) test. 16 Hybridomas that were positive against their corresponding virus (Cody or Cr) by CCIF or FFN were cloned twice by limiting dilution with mouse thymocyte feeder cells. 30 The immunoglobulin isotype of each MAb was determined from hybridoma culture fluids by single radial immunodiffusion using a commercial kit. h Cloned hybridoma cells were grown to a density of 1-2 x 10 6 and injected into pristine-primed BALB/c mice intraperitoneally. Control ascitic fluids were obtained by injecting mice with SP2/0 cells at the same density and using the same procedure as above. The ascites fluids from all the MAbs used in this study, including hybridomas produced in other 1aboratories, ij were collected, centrifugated, and heat inactivated as described previously. 16 Rotavirus-positive and-negative control samples. Fecal samples were obtained from gnotobiotic calves infected with reference BRV G6 strains, NCDV (Cody), OK, ID, and IND and G10 strains B223 and Cr. 23 Cell culture group A human rotaviruses strains Wa (G1), DS1 (G2), M (G3), and 69M (G8) were included as controls. 16 Rotavirus-negative feces were collected from uninfected gnotobiotic calves and field calves. These reference virus strains were tested for reactivity with the MAbs by plaque reduction virus neutralization (PRVN) 16 and ELISA. The reference strain designated Cody was provided by Dr. Alfonso Torres (Foreign Animal Disease Diagnostic Laboratory, APHIS, USDA, Greenport, NY).
Production of polyclonal antiserum. Polyclonal antiserum to BRV was produced by the hyperimmunization of guinea pigs by 3 serial injections of semipurified NCDV G6 BRV (Cody strain). The virus was combined with Freund's complete adjuvant for the first injection, with Freund's incomplete adjuvant for the second, and with phosphate-buffered saline (PBS) (pH 7.4) for the third. Each of the 3 inoculations was administered intramuscularly (2 sites, no adjuvant) and subcutaneously (4 sites) with a 15-day interval between injections. 39 Before inoculation, the animals were free of an-Fixed-cell CCIF and FFN tests. The hybridomas were screened for secretion of antibodies by BRV by using a CCIF test as described previously 37 with the following modifications. Confluent MA 104 cell monolayers were inoculated with the Cody or Cr strains of BRV to produce 80% infectivity. At 16 hr postinoculation, cells were fixed using 80% acetone and stored at -20 C for further use. Hybridomas were screened for the secretion of neutralizing antibodies by FFN as previously described 30 using the Cr and Cody BRV strains.
Specificity of the G6 MAb, BR1603. The VP7 specificity of this G6 MAb was defined in the FFN test using an SA11 x NCDV reassortant rotavirus k that contained the VP7 gene from the NCDV BRV and the VP4 gene from SA11. 21 Specificity of the G10 MAb, BRC11F6. The VP7 specificity of this G10 MAb was defined using western blot as described previously 30 with the following modifications. The strains Cr (G10) and IND (G6) were used as the virus samples in the protein immunoblots, and sodium dodecyl sulfate was not used in the sample buffer. Prestained molecular weight markers were used as controls.
VP7 MAbs to BRV used in ELISA. A nonneutralizing broadly reactive VP7 MAb, Common 60, i was used to detect rotavirus VP7 in the samples. Two G6-specific neutralizing MAbs, IC3 i against the UK strain of BRV 31 and BR 16D3 1 against the NCDV (Cody) strain of BRV previously developed in our laboratory, were used together as a pool for the G6 typing. Two neutralizing G10-specific MAbs, E7, j against the B223 strain of BRV and BRC11F6 against the Cr BRV strain 26 developed as part of the present study, were pooled and used for the G10 typing.
ELISA. The MAbs were purified on Avid AL affinity columns, m and their protein concentrations were determined by a modification of the methods described previously. 28 The affinity-purified MAbs were subjected to a checkerboard titration separately, and then like MAbs were pooled according to their respective G types at the concentrations determined as optimal, ranging from 2 to 4 µg, in carbonate-bicarbonate buffer and used for coating ELISA plates. n Control ascitic fluids were processed, and their protein concentrations were determined as above for use as a rotavirus antibody-negative coating. After overnight incubation at 4 C, nonfat dry milk at a 10% concentration in PBS-TW (pH 7.4) (0.05% Tween 20, 0.5 mM CaCl 2 ) was applied as a blocking reagent for 2 hr at 37 C. Samples were diluted 1:25 in PBS-O.5 mM CaCl 2 and added to duplicate wells coated with capture MAb ascites or antibody-negative coating. Diluent was added to duplicate wells as negative controls. The samples were incubated in the plates overnight at 4 C. A guinea pig hyperimmune serum against bovine group A rotavirus (NCDV strain) was added as the secondary antibody at a 1:2,000 dilution. The plates were incubated for 1 hr at 37 C, and sheep anti-guinea pig IgG conjugated with horseradish peroxidas o was added at a 1:2,000 dilution as the detector reagent. The substrate used was 2,2'-azino-di-3-ethylbenzthiazoline sulfonic acid (ABTS) with a final concentration of 0.03% hydrogen peroxide. The absorbance values were calculated as the mean absorbance at 414 nm in each MAb-coated or negative control well, as measured with a microtitration plate ELISA reader p interfaced to a microcomputer. The cutoff absorbance value for positive samples was calculated as greater than or equal to the mean absorbance at 414 nm of the samples in the rotavirus antibody-negative control wells plus 3 SD.
Results

Virus neutralization titers of G6 and G10 MAbs. The
G6 and G10 MAbs (ascites) were tested in a PRVN assay to characterize their neutralization titers ( Table  1 ). The MAbs IC3 and BR16D3 neutralized the G6 strain NCDV and did not neutralize the G10 strain Cr. The MAb BRC11F6 neutralized the G10 strains B223 Table 2 . Reactivity (mean absorbance at 414 nm) of fecal samples obtained from gnotobiotic calves infected with known strains of group A BRV and of tissue culture reference strains using G serotype-specific MAbs (G6 and G10) in an ELISA. and CR but did not neutralize the G6 strains NCDV or IND. The MAb E7 neutralized the G10 strains B223 and Cr but did not neutralize the G6 strains NCDV or IND (Table 1 ).
Protein specificity of the G6 MAb BR1603 and G10
MAb BRC11F6. The MAb BRl6D3 was shown to be G6 VP7 specific by FFN using the SA11 x NCDV reassortant rotavirus. The protein specificity of the MAb BRC1lF6 was characterized in the western blot analysis. This MAb reacted only with the VP7 protein (34 K) of the G10 Cr strain and not with any of the proteins of the G6 IND strain (data not shown).
Specificity of the MAb-based ELISA. The serotyp-
ing MAb-based ELISAs were G6 and G10 serotype specific ( Table 2 ). The serotype G6 (NCDV, IND, OK, and ID strains)-positive feces reacted with Common 60 and G6 MAbs but did not react with G10 MAbs. The serotype G10 (Cr and B223 strains)-positive feces reacted with Common 60 and G10 MAbs but did not react with the G6 MAbs. The cell culture group A human rotavirus strains Wa (G1), DS1 (G2), M (G3), and 69M (G8) reacted with Common 60 but did not react with the G6 or G10 MAbs. The cutoff absorbance value was determined for each set of plates and was usually between 0.170 and 0.200. Table 3 . Reactivity of BRV-positive field samples with G serotype-specific MAbs (G6 and G10) in an ELISA.
Analysis of the field strains of BRV. The serotyping results for the field strains of BRV from South Dakota, Ohio, Michigan, Nebraska, Washington, and Ontario according to their G types are shown in Table 3 . Of the 308 samples analyzed in the present study, 244 (79%) were determined as positive by using the MAb Common 60, suggesting they contained adequate VP7 for further typing (Table 3 ). Of these 244 potentially typable samples, 54% (131/244) were G6 positive, 14% (35/244) were G10 positive, and 28% (69/244) were nonreactive with G6 or G10. The analysis according to the type of herd (beef versus dairy) of the samples from South Dakota that had adequate numbers of samples from each source was as follows. From a total of 46 samples from South Dakota dairy herds, 40 (87%) reacted with the VP7 Common 60 MAb. Of these 40 typable samples, 19 (47.5%) were typed as G6,7 (17.5%) were typed as G10, 4 (10%) were typed as both G6 and G10, and 10 (25%) were nonreactive with G6 or G10. Of the 43 samples from South Dakota beef herds, 36 (84%) were positive by the Common 60 MAb, of which 24 (67%) were typed as G6, 2 (5.5%) were typed as G10, 2 (5.5%) were typed as both G6 and G10, and 8 (22%) were nonreactive with G6 or G10. Of the 73 samples from South Dakota herds of undetermined type, 61 (84%) reacted with the Common 60 MAb, of which 40 (65.5%) were typed as G6, 7 (11.5%) were typed as G10, 3 (5%) were typed as both G6 and G10, and 11 (18%) were nonreactive with G6 or G10. Of the 70 total samples from Ohio, 58 reacted with the Common 60 MAb (83%) of which 19 (33%) were typed as G6, 13 (22%) were typed as G10, and 26 (45%) were nonreactive with G6 or G10. Of the 33 samples from Michigan, 12 (36%) were positive by the Common 60 MAb, of which 10 (83.3%) were typed as G6, 1 (8.3%) was typed as G10, and 1 (8.3%) was nonreactive with G6 or G10. Of the 26 samples from Nebraska, 22 were positive by the Common 60 MAb (85%), of which 11 (50%) were typed as G6, 4 (18%) were typed as G10, and 7 (32%) were nonreactive with G6 or G10. Only 3 samples from Washington were tested; 2 (67%) were positive by the Common 60 MAb, both of which were typed as G6. Of the 14 samples from Ontario, 13 were positive by the Common 60 MAb (93%) of which 6 (46%) were typed as G6, 1 (8%) was typed as G10, and 6 (46%) were nonreactive with G6 or G10.
Discussion
In this study, an ELISA was developed for the G typing of group A BRV using G6, G10, and a broadly reactive MAb (Common 60). Previous studies have indicated that neutralizing MAbs to the rotavirus outer capsid glycoprotein VP7 are useful for G serotypic classification. 2, 31 Such MAbs may be used in an ELISA for the serotypic characterization of a large number of samples. 2, 31 The G type specificity of our neutralizing MAbs was confirmed as G6 or G10 by classical serologic methods (PRVN) using a unified typing scheme 14 with reference and reassortant rotaviruses. The BRV reference strains, including IND (G6) and Cr (G10) which we used to characterize the specificity of our MAbs, had been typed previously in our laboratory using 2-way cross-neutralization assays and nucleic acid probes. 23 The NCDV VP7 neutralizing MAbs were G6 specific, whereas the Cr VP7 neutralizing MAbs were G10 specific. The G6-and G10-specific MAbs failed to react with other rotavirus G serotypes that have recently been identified in cattle (G1, G2, G3, and G8). 2, 3, 15, 31, 34 Several neutralizing MAbs were originally isolated, but for subsequent use MAbs BR16D3 (G6) and BRC11F6 (G10) were chosen.
Although the MAbs used in the present study were specific for the respective serotypes against which they were developed, monotypes (antigenic variants within a serotype 5 ) can result in failure to detect a BRV-positive field sample, depending upon the universality of the MAbs used in the assay. 9 A good approach to decrease the possible failure of typing a certain field strain due to monotypes in a MAb-based typing assay is to use different purified MAbs (G type specific) pooled together, as was done in the present study. The sensitivity of our ELISA for the typing of BRV field strains was increased over the use of a single G type specific coating MAb (data not shown). Whether the G type MAbs used in the pool react to distinct epitopes on VP7 was not determined.
The ELISA was modified from procedures previously reported. 7 In previous studies, the sensitivity of a rotavirus serotyping ELISA was increased by the incorporation of CaCl 2 into all the buffers. By including 0.5 mM CaCl 2 in all of our ELISA buffers, we also found increased sensitivity in our assay (data not shown).
The results of the distribution of G6 types among diarrheic calves correlate with the findings in the UK 31 and in Argentina. 2 Like these investigators, we found that G6 was the most frequent serotype detected among diarrheic calves (54% of the samples tested). No other G10 MAb-based typing of BRV has been done, although in one study VP4 MAbs (P 11) produced against B223 G10 BRV detected 6.8% of samples with a P11 type. 31 Previously in our laboratory, we used nucleic acid probes representing distinct P and G types of BRV to analyze 102 field samples from diarrheic calves that were positive for group A BRV. 22 Of these samples, 36 .3% (37/102) were G6, 12.7% (13/102) were G10, and 23.5% (24/102) were untypable, which corresponds closely to the percentages we determined using serotyping MAbs in the ELISA. The large number of samples, 28% (69/244), that had enough BRV VP7 to be detected by the broadly reactive MAb (Common 60), but to which neither serotype G6 nor G10 could be assigned may represent other or new serotypes of BRV that may be present in the field but require further characterization. 15 Previous studies from Argentina have indicated that G6 is more prevalent in beef herds (84.7%) that in dairy herds (44%). 2 In addition, dairy herds had higher percentages of samples that were untypable or non-G6 (28%). 2 In the present study, a similar trend was noted. Of 43 samples from South Dakota beef herds, 67% were G6, 5.5% were G10, and 22% were untypable. Of 46 South Dakota dairy herd samples, only 47.5% were G6, 17.5% were G10, and 25% were untypable. Unlike the study conducted in Argentina, 2 our study tested the field BRV strains using both G6 MAbs and G10 MAbs. In addition, we tested a larger number of samples (n = 308) from various parts of North America. This is the first report of a G typing survey of BRV field strains in North America using a MAb-based ELISA. Such data on the distribution of BRV serotypes is important for the development and monitoring of BRV vaccines.
Preliminary studies in our laboratory using cDNA probes representing human (G1, G2, G3, G8) and porcine (G4, G5, G11) rotaviruses have indicated the existence of BRV field strains (a subset of the untypable ones reported in the present study) with G1, G2, G3, and G11 specificities indicative of strains previously thought to occur mainly in humans or swine. 15 In addition to the need to analyze the serotype specificity of BRV for the development and monitoring of efficacious vaccine strategies, recent reports have also documented the existence of G6 and G10 serotypes in humans, serotypes previously thought to occur only in cattle. 1, 10 In previous studies in our laboratory, 3 of 102 samples had a G8 specificity. 22 G8 strains are commonly associated with human populations and are only rarely detected in bovine populations. 31 Moreover, other investigators have found that serotypes previously believed to occur only in humans (G1, G8) also occur in cattle. 3, 15, 22, 31 Thus, another major purpose for the characterization of serotypes of rotaviruses that occur in cattle is to identify and study new or previously unrecognized serotypes that may be associated with Zoonotic infections in the human population. 
